Clinical Trial: Study of GW685698X In Patients With Seasonal Allergic Rhinitis
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Clinical Evaluation of GW685698 for Seasonal Allergic Rhinitis -A Placebo-controlled Study to Determine the Non-inferiority of GW685698 Over Fluticasone Propionate Using a
Brief Summary: This study was designed to compare the efficacy and safety of an investigational nasal spray compared with placebo nasal spray and commonly used drug in the treatment of seasonal allergic rhinitis. Allergic rhinitis is an inflammatory disorder of the upper airway that occurs following allergen exposure. The focus of this study, seasonal allergic rhinitis (SAR), is one type of allergic rhinitis that is triggered by the pollen from trees, grasses, and weeds. Typical symptoms are sneezing, nasal congestion and pruritus, rhinorrhea, and pruritic, watery, red eyes.
Detailed Summary:
Sponsor: GlaxoSmithKline
Current Primary Outcome: Mean change from baseline over the entire treatment period in three total nasal symptom scores.
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Mean change from baseline over the entire treatment period in four total nasal symptom scores.
- Mean change from baseline over the entire treatment period in individual total nasal symptom scores.
Original Secondary Outcome: Same as current
Information By: GlaxoSmithKline
Dates:
Date Received: August 11, 2006
Date Started: February 2005
Date Completion:
Last Updated: April 11, 2013
Last Verified: May 2012
